Stocktoria
Drugs Made In America Acquisition Corp. DMAA
Nasdaq · XNAS · stock · Blank Checks · website · IPO 2025-01-28
Drugs Made In America Acquisition Corp. financials (annual, from 10-K)
| Metric | FY2025 |
|---|---|
| Operating income | -$2.8M |
| Net income | $5.9M |
| Operating cash flow | -$539,187 |
| Cash & equivalents | $6,137 |
| Total assets | $239.9M |
| Total liabilities | $7.3M |
| Shareholders' equity | -$7.3M |
Source: SEC EDGAR filings · CIK 0002028614 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.